Screener
Insmed INSM EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Insmed’s reported figures.
Based on trailing twelve months.
The source filing: Insmed’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104506-26-000041
FAQ
- What is Insmed's EBITDA margin?
- Insmed (INSM) reported EBITDA margin of -72.1% in Q2 2026.
- How has Insmed's EBITDA margin changed year-over-year?
- Insmed's EBITDA margin increased by 71.1% year-over-year, from -249.3% to -72.1%.
- What is the long-term trend for Insmed's EBITDA margin?
- Over 5 years (2020 to 2025), Insmed's EBITDA margin has grown at a 5.4% compound annual growth rate (CAGR), from -155.8% to -202.9%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Insmed's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude